BioMarin Pharmaceuticals Inc BMRN
$68.53
-2.43%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-06-04 | View → |
| 8-K | 8-K | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-05-21 | View → |
| 4 | FORM 4 | 2026-05-11 | View → |
| 10-Q | 10-Q | 2026-05-05 | View → |
| 8-K | 8-K | 2026-05-04 | View → |
| 8-K | 8-K | 2026-04-27 | View → |
| 8-K | 8-K | 2026-04-23 | View → |
| DEF 14A | DEF 14A | 2026-04-21 | View → |
| 4 | FORM 4 | 2026-03-19 | View → |
| 4 | FORM 4 | 2026-03-19 | View → |
| 4 | FORM 4 | 2026-03-19 | View → |
| 4 | FORM 4 | 2026-03-19 | View → |
| 4 | FORM 4 | 2026-03-18 | View → |
| 4 | FORM 4 | 2026-03-18 | View → |
| 4 | FORM 4 | 2026-03-17 | View → |
| 4 | FORM 4 | 2026-03-17 | View → |
| 4 | FORM 4 | 2026-03-17 | View → |
| 4 | FORM 4 | 2026-03-17 | View → |
| 8-K | 8-K | 2026-03-16 | View → |
| 4 | FORM 4 | 2026-03-12 | View → |
| 4 | FORM 4 | 2026-02-26 | View → |
| 4 | FORM 4 | 2026-02-26 | View → |
| 4 | FORM 4 | 2026-02-26 | View → |
| 4 | FORM 4 | 2026-02-26 | View → |
| 10-K | 10-K | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-23 | View → |
| 8-K | 8-K | 2026-02-12 | View → |
| 8-K | 8-K | 2026-01-29 | View → |
| 8-K | 8-K | 2026-01-26 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $68.53
- Market Cap
- $13.60 billion
- 52-Week Range
- $49.26 – $70.98
- Average Volume
- 2.00 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.